175 related articles for article (PubMed ID: 26147064)
21. Molecular weight determination of heparosan- and chondroitin-like capsular polysaccharides: figuring out differences between wild -type and engineered Escherichia coli strains.
Restaino OF; D'ambrosio S; Cassese E; Ferraiuolo SB; Alfano A; Ventriglia R; Marrazzo A; Schiraldi C; Cimini D
Appl Microbiol Biotechnol; 2019 Aug; 103(16):6771-6782. PubMed ID: 31222385
[TBL] [Abstract][Full Text] [Related]
22. Characterization of acidic polysaccharides from the mollusks through acid hydrolysis.
Cao J; Wen C; Lu J; Teng N; Song S; Zhu B
Carbohydr Polym; 2015 Oct; 130():268-74. PubMed ID: 26076626
[TBL] [Abstract][Full Text] [Related]
23. Polysaccharide-based polyelectrolyte multilayer surface coatings can enhance mesenchymal stem cell response to adsorbed growth factors.
Almodóvar J; Bacon S; Gogolski J; Kisiday JD; Kipper MJ
Biomacromolecules; 2010 Oct; 11(10):2629-39. PubMed ID: 20795698
[TBL] [Abstract][Full Text] [Related]
24. High cell density cultivation of recombinant Escherichia coli strains expressing 2-O-sulfotransferase and C5-epimerase for the production of bioengineered heparin.
Zhang J; Suflita M; Li G; Zhong W; Li L; Dordick JS; Linhardt RJ; Zhang F
Appl Biochem Biotechnol; 2015 Mar; 175(6):2986-95. PubMed ID: 25586487
[TBL] [Abstract][Full Text] [Related]
25. High cell density cultivation of a recombinant E. coli strain expressing a key enzyme in bioengineered heparin production.
Restaino OF; Bhaskar U; Paul P; Li L; De Rosa M; Dordick JS; Linhardt RJ
Appl Microbiol Biotechnol; 2013 May; 97(9):3893-900. PubMed ID: 23318839
[TBL] [Abstract][Full Text] [Related]
26. Online reverse phase-high-performance liquid chromatography-fluorescence detection-electrospray ionization-mass spectrometry separation and characterization of heparan sulfate, heparin, and low-molecular weight-heparin disaccharides derivatized with 2-aminoacridone.
Galeotti F; Volpi N
Anal Chem; 2011 Sep; 83(17):6770-7. PubMed ID: 21780812
[TBL] [Abstract][Full Text] [Related]
27. High-throughput method for in process monitoring of 3-O-sulfotransferase catalyzed sulfonation in bioengineered heparin synthesis.
Lin L; Yu Y; Zhang F; Zhang X; Linhardt RJ
Anal Biochem; 2019 Dec; 586():113419. PubMed ID: 31518551
[TBL] [Abstract][Full Text] [Related]
28. Surface modification of biomaterials to control adhesion of cells.
Kirchhof K; Groth T
Clin Hemorheol Microcirc; 2008; 39(1-4):247-51. PubMed ID: 18503133
[TBL] [Abstract][Full Text] [Related]
29. Heparin/chitosan nanoparticle carriers prepared by polyelectrolyte complexation.
Liu Z; Jiao Y; Liu F; Zhang Z
J Biomed Mater Res A; 2007 Dec; 83(3):806-12. PubMed ID: 17559117
[TBL] [Abstract][Full Text] [Related]
30. Heparin-like heparan sulfate from rabbit cartilage.
Parra A; Veraldi N; Locatelli M; Fini M; Martini L; Torri G; Sangiorgi L; Bisio A
Glycobiology; 2012 Feb; 22(2):248-57. PubMed ID: 21933839
[TBL] [Abstract][Full Text] [Related]
31. Heparosan-derived heparan sulfate/heparin-like compounds: one kind of potential therapeutic agents.
Li P; Sheng J; Liu Y; Li J; Liu J; Wang F
Med Res Rev; 2013 May; 33(3):665-92. PubMed ID: 22495734
[TBL] [Abstract][Full Text] [Related]
32. Capillary Electrophoresis-Mass Spectrometry for the Analysis of Heparin Oligosaccharides and Low Molecular Weight Heparin.
Sun X; Lin L; Liu X; Zhang F; Chi L; Xia Q; Linhardt RJ
Anal Chem; 2016 Feb; 88(3):1937-43. PubMed ID: 26714061
[TBL] [Abstract][Full Text] [Related]
33. Optimization of bioprocess conditions improves production of a CHO cell-derived, bioengineered heparin.
Baik JY; Dahodwala H; Oduah E; Talman L; Gemmill TR; Gasimli L; Datta P; Yang B; Li G; Zhang F; Li L; Linhardt RJ; Campbell AM; Gorfien SF; Sharfstein ST
Biotechnol J; 2015 Jul; 10(7):1067-81. PubMed ID: 26037948
[TBL] [Abstract][Full Text] [Related]
34. Coating electrospun chitosan nanofibers with polyelectrolyte multilayers using the polysaccharides heparin and N,N,N-trimethyl chitosan.
Almodóvar J; Kipper MJ
Macromol Biosci; 2011 Jan; 11(1):72-6. PubMed ID: 20976723
[TBL] [Abstract][Full Text] [Related]
35. Enzymatic synthesis of heparan sulfate and heparin.
Joice A; Raman K; Mencio C; Quintero MV; Brown S; Nguyen TK; Kuberan B
Methods Mol Biol; 2015; 1229():11-9. PubMed ID: 25325939
[TBL] [Abstract][Full Text] [Related]
36. Heparin binding by murine recombinant prion protein leads to transient aggregation and formation of RNA-resistant species.
Vieira TC; Reynaldo DP; Gomes MP; Almeida MS; Cordeiro Y; Silva JL
J Am Chem Soc; 2011 Jan; 133(2):334-44. PubMed ID: 21142149
[TBL] [Abstract][Full Text] [Related]
37. Enzymatic preparation of heparin disaccharides as building blocks in glycosaminoglycan synthesis.
Kim YS; Thanawiroon C; Bazin HG; Kerns RJ; Linhard RJ
Prep Biochem Biotechnol; 2001 May; 31(2):113-24. PubMed ID: 11426699
[TBL] [Abstract][Full Text] [Related]
38. Expression and secretion of glycosylated heparin biosynthetic enzymes using Komagataella pastoris.
Englaender JA; Zhu Y; Shirke AN; Lin L; Liu X; Zhang F; Gross RA; Koffas MA; Linhardt RJ
Appl Microbiol Biotechnol; 2017 Apr; 101(7):2843-2851. PubMed ID: 27975137
[TBL] [Abstract][Full Text] [Related]
39. Heparin sodium compliance to the new proposed USP monograph: elucidation of a minor structural modification responsible for a process dependent 2.10 ppm NMR signal.
Mourier PA; Guichard OY; Herman F; Viskov C
J Pharm Biomed Anal; 2011 Jan; 54(2):337-44. PubMed ID: 20934294
[TBL] [Abstract][Full Text] [Related]
40. The impact of preparation parameters on typical attributes of chitosan-heparin nanohydrogels: particle size, loading efficiency, and drug release.
Shahbazi MA; Hamidi M
Drug Dev Ind Pharm; 2013 Nov; 39(11):1774-82. PubMed ID: 23136990
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
